Biovitae is the Lead Sponsor of the Built Environment Infection Prevention Initiative (BEIPI), presented at the Healthcare Estates Conference in Manchester, UK on the 21st of October 2025. The project introduces a new approach to hospital design, integrating infection prevention into every phase of the construction, operation, and maintenance of healthcare facilities.

Biovitae’s support stems from full alignment with its mission: promoting infection prevention in shared environments through its patented LED technology that uses only visible light to continuously eliminate bacteria and viruses, ensuring safety for people and long-term environmental sustainability.

Furthermore, the initiative fully fits Biovitae’s vision for its contribution to the fight against Antimicrobial Resistance (AMR), considered one of the most serious global health emergencies, with projections indicating up to 10 million deaths per year by 2050 and an estimated economic impact of over $100 trillion (Source: World Health Organization).

Many of these infections are linked to avoidable design flaws, such as inadequate ventilation or unsafe drainage systems, which compromise hygiene and safety inside healthcare facilities. The BEIPI project directly connects to the work of the Joint Research Platform (JRP) for Healthcare Infrastructures, of which Biovitae is a Platinum Member, promoted by the Politecnico di Milano and dedicated to developing the Hospital of the Future.

“Infection-safe” as the new standard for safer hospitals

The goal of the conference is to propose a new paradigm in hospital design. With support from the NHS New Hospitals Programme (NHP) and IHEEM, the BEIPI group will promote research, policies, and guidelines to make “infection-safe” design the new standard for the healthcare sector.

As hospitals evolve, even walls, airflow, and lighting systems must take an active role in infection control. Because the best way to fight infections is to design prevention from the very beginning.

Biovitae and BEIPI: A shared vision

“The first requirement of a hospital is that it should do the sick no harm,” said Ron Finlay, Chair of BEIPI, echoing Florence Nightingale. “With billions being invested in new hospital construction, we have an unprecedented opportunity to ensure these facilities help prevent, rather than spread, infections”.

A principle fully aligned with Biovitae’s vision, as underlined by Mauro Pantaleo, the company’s CEO:

“Biovitae’s participation in this initiative reflects our ongoing commitment to prevention through innovation. Our technology converges on a goal shared with BEIPI: making hospital design an integral part of a global prevention strategy, uniting science, technology, and design to build environments that are truly safe for everyone who lives and works in them”.

BEIPI’s contribution

BEIPI is a Special Interest Group of the Healthcare Infection Society (HIS) established in 2025, which for the first time brought together leading experts in architecture, engineering, healthcare, and research – including Arup, Laing O’Rourke, UCLH, P+HS Architects, and others – to define how to integrate infection prevention into hospital design “from day one”.

Published by the Healthcare Infection Society (HIS), the BEIPI report shows how integrating microbiological safety principles into healthcare infrastructure can:

  • reduce deaths related to infections,

  • minimize remediation costs,

  • strengthen the global fight against antimicrobial resistance—the so-called “silent pandemic.”

Learn more about the Built Environment Infection Prevention Initiative (BEIPI) and download the full report on the Healthcare Infection Society website.